WellSky to Deliver In-Home Protocols for Patients With Heart Failure

WellSky’s technology platform and provider networks will coordinate the execution of in-home, heart failure protocols to lower hospital readmissions at The Ohio State University Wexner Medical Center

WellSky, a leading health and community care technology company, today announced they will work with The Ohio State University Wexner Medical Center to implement in-home, heart failure care protocols that are intended to reduce hospital readmissions for patients discharged after admission for heart failure.

Heart failure is a leading cause of hospital readmission in the United States, with an average 30-day readmission rate of nearly 25 percent, generating more than one million hospital stays annually.

The WellSky Care Coordination platform and network of personal care and home health providers coordinates the delivery of care to heart failure patients who are voluntarily enrolled in the program at the time of hospital discharge. The WellSky protocols leverage cutting-edge ReDS™ technology, a system that can view the inside of the lungs of heart failure patients. Using this technology from Sensible Medical, clinicians can quickly and accurately assess lung fluid in heart failure patients, enabling the deployment of customized care interventions that are intended to prevent hospital readmissions.

Dr. Dan Bensimhon, a Medical Director of WellSky and Medical Director of Cone Health’s Advanced Heart Failure Clinic, a national leader in designing heart failure care at-home pathways, has been instrumental in designing these protocols. In applying the protocols in multiple health systems across North Carolina, Dr. Bensimhon has realized a 40 percent decrease in readmission rates. In a meta-analysis comprised of seven published clinical studies, researchers found a 60 percent reduction in heart failure readmission rates on average when using the ReDS technology, as compared to standard post-discharge heart failure care.

This new, transformational program powers collaboration between heart failure cardiologists, telehealth clinicians, nurses, and personal caregivers to optimize the care of these patients in the home. Dr. Brent Lampert and Dr. Raymond Benza will lead the program at Ohio State Wexner Medical Center.

“WellSky is excited to work with Dr. Lampert and Dr. Benza on the implementation of this innovative protocol that enables advanced clinical and operational workflows for complex care delivery,” said Bill Miller, WellSky CEO. “By integrating care coordination technology and scaled, connected provider networks, hospital systems can deliver improved outcomes through coordinated condition-specific protocols.”

SourceWellSky®
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy